CD8A and neoplasm: With advances in artificial intelligence (AI) and machine-learning, we should consider creating models based on gene signatures that portend a robust tumor immune microenvironment and use this to help make decisions along with radiomics-based AI to help predict the tumor microenvironment or use of pathology-based AI looking at density of CD3+ and CD8+ T cells [96–98].